DocGo (DCGO)

Search documents
DocGo (DCGO) - 2024 Q2 - Quarterly Report
2024-08-07 20:37
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39618 DocGo Inc. (Exact Name of Registrant as Specified in Its Charter) | --- | --- | |----------------------- ...
DocGo (DCGO) - 2024 Q2 - Quarterly Results
2024-08-07 20:19
Exhibit 99.1 DocGo Announces Strong Second Quarter 2024 Results Company Raises Cash Flow From Operations Guidance to $80-$90 Million, Reiterates 2024 Revenue Guidance of $600-$650 Million and Adjusted EBITDA Guidance of $65-$75 Million 1 Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time (Note Corrected Call Information Below) NEW YORK, NY, August 7, 2024 – DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technologyenabled mobile health services, today an ...
DocGo (DCGO) - 2024 Q1 - Earnings Call Transcript
2024-05-11 02:10
DocGo Inc. (NASDAQ:DCGO) Q1 2024 Earnings Conference Call May 8, 2024 5:00 PM ET Company Participants Mike Cole - Director, Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Ryan MacDonald - Needham Richard Close - Canaccord Genuity David Larsen - BTIG Kieran Ryan - Deutsche Bank Sarah James - Cantor Fitzgerald David Grossman - Stifel Operator Greetings and welcome to the DocGo First Quarter 2024 Earnings Conference Call. [Oper ...
DocGo Inc. (DCGO) Matches Q1 Earnings Estimates
Zacks Investment Research· 2024-05-08 23:46
DocGo Inc. (DCGO) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate. This compares to loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post earnings of $0.13 per share when it actually produced earnings of $0.06, delivering a surprise of -53.85%.Over the last four quarters, the company has not been able to surpass consensus EPS estimates.Motion Acquisition, which belongs ...
DocGo (DCGO) - 2024 Q1 - Quarterly Report
2024-05-08 20:36
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to DocGo Inc. (Exact Name of Registrant as Specified in Its Charter) | Delaware | 85-2515483 | | --- | --- | | (State or Other Jurisdiction ...
DocGo (DCGO) - 2024 Q1 - Quarterly Results
2024-05-08 20:13
Exhibit 99.1 DocGo Announces Strong First Quarter 2024 Results Company Reports First Quarter Net Income of $10.6 Million and Record Adjusted EBITDA of $24.1 Million 1 Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time NEW YORK, NY, May 8, 2024 – DocGo Inc. (Nasdaq: DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended March 31, 2024. First Quarter 2024 Financial Highli ...
DocGo Announces Repurchases of Common Stock and Adoption of 10b5-1 Trading Plan for Share Repurchase Program
Businesswire· 2024-03-14 11:35
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that as of March 12, 2024, it has repurchased a total of 1.25 million shares of its common stock at an average of $3.88 per share under its share repurchase program announced on January 31, 2024 (the “Repurchase Program”). Pursuant to the Repurchase Program, DocGo is authorized to purchase up to $36 million of its common stock during a 6-month peri ...
DocGo (DCGO) - 2023 Q4 - Earnings Call Transcript
2024-02-29 02:04
DocGo, Inc. (NASDAQ:DCGO) Q4 2023 Earnings Conference Call February 28, 2024 5:00 PM ET Company Participants Mike Cole - Vice President, Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Ryan MacDonald - Needham & Company David Larsen - BTIG Michael Latimore - Northland Capital Markets Sarah James - Cantor Fitzgerald Richard Close - Canaccord David Grossman - Stifel Pito Chickering - Deutsche Bank Operator Good day, ladies and ...
DocGo Inc. (DCGO) Q4 Earnings Lag Estimates
Zacks Investment Research· 2024-02-29 00:06
DocGo Inc. (DCGO) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -53.85%. A quarter ago, it was expected that this company would post earnings of $0.07 per share when it actually produced earnings of $0.05, delivering a surprise of -28.57%.Over the last four quarters, the company has ...
DocGo (DCGO) - 2023 Q4 - Annual Report
2024-02-27 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 For the transition period from to Commission File Number 001-39618 DocGo Inc. (Exact name of Registrant as specified in its Charter) | Delaware | 85-2515483 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identif ...